Skip to main content
Peter Sereny, MD, Internal Medicine, Brooklyn, NY

PeterSerenyMD

Internal Medicine Brooklyn, NY

CEO, Executive Chairman

Dr. Sereny is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Sereny's full profile

Already have an account?

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1973 - 1975
  • University of Connecticut (New Britain)
    University of Connecticut (New Britain)Internship, Internal Medicine, 1972 - 1973
  • Albert Einstein College of Medicine
    Albert Einstein College of MedicineClass of 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1975 - Present
  • NY State Medical License
    NY State Medical License 1973 - 2025
  • CT State Medical License
    CT State Medical License 1975 - 2025
  • IEEELife Member

Awards, Honors, & Recognition

  • Excellence in Healthcare Software, two categories Microsoft, 2001
  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
  • Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2014

Professional Memberships

Other Languages

  • Hungarian, French, Spanish

Industry Relationships

  • Founder, CEO, Executive Chairman, RESoft LLCPremier Real Estate Brokerage software development company2016 - 2020
  • Founder, CEO, Chairman, Principal Broker, Brick&Mortar LLCNYC butique Real Estate Brokeraage2012 - 2020
  • Founder, Ex-CEO, Ex-Chairman, Amkai LLCLead company to market dominance - today 83% of ASCs are using Amkai Charts2004 - 2014
  • Founder, Ex-CEO, Ex-Chairman, HealthISLead company to market dominance - 37% US market share1986 - 2002